Cardiovascular diseases (CVD) remain the leading cause of death in the USA. Cardiomyocytes (CMs) derived from human pluripotent stem cells (hPSCs) provide a valuable cell source for regenerative therapy, disease modeling, and drug screening. Here, we established a hPSC line integrated with a mCherry fluorescent protein driven by the alpha myosin heavy chain (aMHC) promoter, which could be used to purify CMs based on the aMHC promoter activity in these cells. Combined with a fluorescent voltage indicator, ASAP2f, we achieved a dual reporter CM platform, which enables purification and characterization of CM subtypes and holds great potential for disease modeling and drug discovery of CVD.
CITATION STYLE
Jiang, Y., Bao, X., & Lian, X. L. (2021). A dual cardiomyocyte reporter model derived from human pluripotent stem cells. Stem Cell Research and Therapy, 12(1). https://doi.org/10.1186/s13287-021-02341-6
Mendeley helps you to discover research relevant for your work.